| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JNCI/80.13.1045 |
| P698 | PubMed publication ID | 2457709 |
| P2093 | author name string | Ho SM | |
| Merk FB | |||
| Kwan PW | |||
| Leav I | |||
| Ofner P | |||
| Damassa D | |||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1045-1053 | |
| P577 | publication date | 1988-09-01 | |
| P1433 | published in | Journal of the National Cancer Institute | Q400279 |
| P1476 | title | Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats | |
| P478 | volume | 80 |
| Q37599474 | A novel role for raloxifene nanomicelles in management of castrate resistant prostate cancer. |
| Q36665050 | A review of the carcinogenic potential of bisphenol A. |
| Q37265869 | Alcohol exposure in utero increases susceptibility to prostate tumorigenesis in rat offspring |
| Q43732919 | Altered expression of extracellular matrix and proteinases in Noble rat prostate gland after long-term treatment with sex steroids |
| Q36742757 | An evaluation of evidence for the carcinogenic activity of bisphenol A. |
| Q31912859 | Analysis of glycoconjugate patterns of normal and hormone-induced dysplastic Noble rat prostates, and an androgen-independent Noble rat prostate tumor, by lectin histochemistry and protein blotting |
| Q36401971 | Androgen hormone action in prostatic carcinogenesis: stromal androgen receptors mediate prostate cancer progression, malignant transformation and metastasis. |
| Q35843249 | Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth |
| Q35190865 | Animal models for the study of prostate carcinogenesis |
| Q28391888 | Anti-inflammatory activity of soy and tea in prostate cancer prevention |
| Q35131296 | Antiestrogens and selective estrogen receptor modulators reduce prostate cancer risk |
| Q30354593 | Bisphenol A Disrupts HNF4α-Regulated Gene Networks Linking to Prostate Preneoplasia and Immune Disruption in Noble Rats. |
| Q24314248 | CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells |
| Q38471556 | Circulating steroid hormones in prostate carcinogenesis. Part 2: Estrogens |
| Q39037694 | Clinical implications of estrone sulfate measurement in laboratory medicine |
| Q30686407 | Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma |
| Q36352079 | Current and future status of prostate cancer chemoprevention |
| Q37920776 | Cytokine and endocrine signaling in prostate cancer |
| Q28371716 | Development of androgen-independent carcinomas from androgen-dependent preneoplastic lesions in the male accessory sex organs of rats treated with 3,2'-dimethyl-4-aminobiphenyl and testosterone propionate |
| Q35903630 | Developmental estrogen exposures predispose to prostate carcinogenesis with aging |
| Q24648201 | Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4 |
| Q61450295 | Differential expression of estrogen receptors α and β in adult rat accessory sex glands and lower urinary tract |
| Q73249713 | Effect of combined testosterone and estradiol-17 beta treatment on the metabolism of E2 in the prostate and liver of noble rats |
| Q28393584 | Endocrine disruptors and prostate cancer risk |
| Q24651457 | Endocrine-disrupting chemicals: an Endocrine Society scientific statement |
| Q28070418 | Environmental endocrine disruptors: Effects on the human male reproductive system |
| Q38766770 | Estrogen Receptor Alpha (ERα)-Associated Fibroblasts Promote Cell Growth in Prostate Cancer |
| Q35099011 | Estrogen action and prostate cancer |
| Q39700571 | Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion. |
| Q35787781 | Estrogen receptor expression in prostate cancer and premalignant prostatic lesions |
| Q37686148 | Estrogen receptors and function in the male reproductive system |
| Q35196710 | Estrogens and prostate cancer: etiology, mediators, prevention, and management. |
| Q38354934 | Expression and regulation of metallothionein mRNA levels in the prostates of noble rats: lack of expression in the ventral prostate and regulation by sex hormones in the dorsolateral prostate |
| Q53663243 | Expression of estrogen receptor β and Ki 67 in benign & malignant human prostate lesions by immunohistochemistry. |
| Q36409841 | Gene expression profiling identifies lobe-specific and common disruptions of multiple gene networks in testosterone-supported, 17beta-estradiol- or diethylstilbestrol-induced prostate dysplasia in Noble rats |
| Q37498422 | Genetic polymorphisms of estrogen receptor alpha and catechol-O-methyltransferase genes in Turkish patients with familial prostate carcinoma |
| Q79080811 | Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol‐O‐methyltransferase are associated with familial prostate carcinoma risk in a Japanese population |
| Q33708557 | Growth hormone and prostate cancer: guilty by association? |
| Q42484057 | Hormonal regulation of nuclear type II estrogen binding sites in the dorsolateral prostate of Noble rats |
| Q34360616 | Human prostate cancer risk factors |
| Q35753227 | Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat. |
| Q28376078 | Lobe specific effects of testosterone and estrogen on 3,2'-dimethyl-4-aminobiphenyl-induced rat prostate carcinogenesis |
| Q37162089 | Loss of NADPH quinone oxidoreductase in the prostate and enhanced serum levels of cytokine-induced neutrophil chemoattractant 2alpha in hormone-stimulated noble rats: potential role in prostatic intraepithelial neoplasia development |
| Q36407468 | Management of prostate cancer. Part 1: chemoprevention |
| Q42083843 | Metabolism of estradiol and estrone in organ cultures of dorsolateral and ventral prostate of untreated and sex hormone-implanted rats |
| Q42436492 | Neonatal exposure to diethylstilbestrol permanently alters the basal and 17 beta-estradiol induced expression of c-fos proto-oncogene in mouse urethroprostatic complex |
| Q53671417 | New tools in therapeutic research--prostatic cancer and models. |
| Q33642456 | Perinatal exposure to oestradiol and bisphenol A alters the prostate epigenome and increases susceptibility to carcinogenesis |
| Q35753329 | Pharmacogenetics of human androgens and prostate cancer--an update. |
| Q44124758 | Progressive prostate hyperplasia in adult prolactin transgenic mice is not dependent on elevated serum androgen levels |
| Q35786210 | Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions |
| Q38669798 | Prostate Cancer Risk and DNA Methylation Signatures in Aging Rats following Developmental BPA Exposure: A Dose-Response Analysis. |
| Q35547017 | Prostate Development and Carcinogenesis |
| Q33847495 | Prostate cancer prevention: review of target populations, pathological biomarkers, and chemopreventive agents |
| Q35190824 | Prostatic intraepithelial neoplasia (PIN): Current concepts |
| Q43730216 | Purification and characterization of nuclear type II [(3)H]estradiol binding sites from the rat uterus: covalent labeling with [(3)H]luteolin |
| Q33637134 | Regulation of cell cycle and RNA transcription genes identified by microarray analysis of PC-3 human prostate cancer cells treated with luteolin |
| Q34220101 | Research resource: estrogen-driven prolactin-mediated gene-expression networks in hormone-induced prostatic intraepithelial neoplasia |
| Q34417164 | Role of 5a-reductase inhibitors and selective estrogen receptor modulators as potential chemopreventive agents for prostate cancer. |
| Q43570316 | Selective estrogen receptor modulators for the chemoprevention of prostate cancer |
| Q42558944 | Sequential observation of rat prostate lesion development induced by 3,2'-dimethyl-4-aminobiphenyl and testosterone |
| Q83169245 | Sex hormone-induction and dietary modulation of Prostatic Adenocarcinoma (PA) in animal models |
| Q33295021 | Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat. |
| Q35850102 | The EPI bioassay identifies natural compounds with estrogenic activity that are potent inhibitors of androgenic pathways in human prostate stromal and epithelial cells |
| Q54647555 | The anti-oestrogen fulvestrant (ICI 182,780) reduces the androgen receptor expression, ERK1/2 phosphorylation and cell proliferation in the rat ventral prostate. |
| Q36488068 | The role of estrogens and estrogen receptors in normal prostate growth and disease |
Search more.